Q-omics provides the consensus-scored SNORA10 profile across patient tissues and cancer cell-line models. Additionally, SNORA10 RNA expression shows 1 significant drug associations, with the highest sampling consensus in Metastatic_Urothelial_Carcinoma.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for SNORA10 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with SNORA10 in patient tissues and cancer cell lines. In patient samples, SNORA10 shows the broadest associations at the RNA and protein expression levels, with Metastatic_Urothelial_Carcinoma recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Drug	1	Metastatic_Urothelial_Carcinoma (1)	view →